Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Mesothelioma × Magnesium Sulfate × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Mesothelioma 1 Leukemia, Myeloid, Acute 1 Colorectal Cancer Screening 1

Interventions

Carboplatin 4 pembrolizumab 3 fludarabine 2 Pemetrexed 2 Nivolumab 2 Ipilimumab 2 Cyclophosphamide 2 Cisplatin 2 tremelimumab 1 osimertinib 1 olaparib 1 fludarabine phosphate 1 durvalumab 1 atezolizumab 1 Tumor Burden 1 Thoracoscopy 1 Tablets 1 Saline Solution 1 Quality of Life 1 Observation 1 Magnesium Sulfate 1 Injections 1 Histocompatibility Testing 1 Fluorodeoxyglucose F18 1 Exercise Therapy 1 Combined Modality Therapy 1 Cell- and Tissue-Based Therapy 1 Blood Specimen Collection 1 Blood Component Removal 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05730816 2025-11-21

MAGIC-AKI

Brigham and Women's Hospital

Phase 2 Recruiting

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡